throbber

`

`Editor: Donna Balado
`Managing Editor: jennifer Schmidt
`Marketing Manager: Christine Kushner
`
`Copyright © 1999 Lippincott Wllliams & Wilkins
`
`351 West Camden Street
`Baltimore, Maryland 21201—2436 USA
`
`227 East Washington Square
`Philadelphia, PA 19106
`
`All rights reserved. This book is protected by copyright. No part of this book may be re-
`produced in any form or by any means, including photocopying, or utilized by any infor—
`mation storage and retrieval system'without written permission from the copyright owner.
`
`The publisher is not responsible (as a matter of product liability, negligence, or otherwise)
`for any injury resulting from any material contained herein. This publication contains in—
`formation relating to general principles of medical care which should not be construed as
`specific instructions for individual patients. Manufacturers’product information and pack—
`age inserts should be reviewed for current information, including contraindications,
`dosages, and precautions.
`
`Printed in the United States ofAmerica
`
`Library of Congress Cataloging-in-Publication Data
`
`Ansel, Howard C., 1933—
`Pharmaceutical dosage forms and drug delievery systems / Howard C.
`Ansel, Lode. Allen, Jr, Nicholas G. Popovich. —— 7th ed.
`p.
`cm.
`Includes bibliographical references and index.
`ISBN 0—683—30572—7
`2. Drug delivery systems.
`1. Drugs—Dosage forms.
`11. Popovich, Nicholas G.
`III. Title.
`[DNLM: 1. Dosage Forms.
`2. Drug Delivery Systems, QV 785 A618i 1999]
`RS200.A57
`1999
`615’.1—dc21
`DNLM/DLC
`for Library of Congress
`
`1. Allen, Lode.
`
`99—17498
`CIP
`
`The publishers have made every effort to trace the copyright holders for borrowed material. Ifthey
`have inadvertently overlooked any, they will be pleased to make the necessary arrangements at
`the first opportunity.
`-
`
`The use of portions of the text of USP23/NF18, copyright 1994, is by permission of the USP
`Convention, Inc. The Convention is not responsible for any inaccuracy of quotation or for
`any false or misleading implication that may arise from separation of excerpts from the
`original context or by obsolescence resulting from publication of a supplement.
`
`To purchase additional copies of this book call our customer service department at (800)
`638—3030 or fax orders to (301) 824—7390. International customers should call (301)
`714—2324.
`
`99 00 01 02
`1 2 3 4 5 6 7 8 9 10
`
`AstraZeneca Exhibit 2096 p. 2
`
`

`

`
`
`Contents
`
`Preface
`
`Acknowledgments
`
`Section I. PRINCIPLES OF DOSAGE FORM DESIGN AND DEVELOPMENT
`
`I
`
`2
`
`3
`
`4
`
`5
`
`Introduction to Drugs and Pharmacy
`
`New Drug Development and Approval Process
`
`Dosage Form Design: Pharmaceutic and
`Formulation Considerations
`'
`
`Dosage Form Design: Biopharmaceutic and
`Pharmacokinetic Considerations
`
`Current Good Manufacturing Practices and Good
`Compounding Practices
`
`Section II. SOLID DOSAGE FORMS AND MODIFIED-RELEASE DRUG DELIVERY SYSTEMS
`
`6
`
`7
`
`8
`
`Powders and Granules
`
`Capsules and Tablets
`
`‘
`
`Modified~Release Dosage Forms and Drug Delivery Systems
`
`Section III. SEMI-SOLID AND TRANSDERMAL SYSTEMS
`
`9
`
`IO
`
`Ointments, Creams, and Gels
`
`Transdermal Drug Delivery Systems
`
`v
`
`vii
`
`1
`
`23
`
`60
`
`101
`
`142
`
`164
`
`179
`
`229
`
`_
`
`'244
`
`263
`
`ix'
`
`AstraZeneca Exhibit 2096 p. 3
`
`

`

`x
`
`Contents
`
`Section IV. PHARMAEEUTICAL INSERTS
`
`II
`
`Suppositories and Inserts
`
`Section V. LIQUID DOSAGE FORMS
`
`I 2
`
`I3
`
`S olutions
`
`Disperse Systems
`
`Section VI. STERILE DOSAGE FORMS AND DELIVERY SYSTEMS
`
`I 4
`
`I 5
`
`I6
`
`Parenterals
`
`Biologicals
`
`Ophthalmic Solutions and Suspensions
`
`Section VII. NOVEL AND ADVANEED DOSAGE FORMS, DELIVERY SYSTEMS, AND DEVIEES
`
`Radiopharmaceuticals
`
`Products of Biotechnology
`
`Novel Dosage Forms and Drug Delivery Technologies
`
`Systems and Techniques of Pharmaceutical Measurement
`
`I 7
`
`I8
`
`I9
`
`Appendix
`
`Index
`
`279
`
`296
`
`346
`
`397
`
`450
`
`469
`
`487
`
`503
`
`535
`
`552
`
`563
`
`AstraZeneca Exhibit 2096 p. 4
`
`

`

`Section V. Liquid Dosage Forms
`
`' SOLUTIONS
`
`
`
`Chapter at a Glance
`
`Solubility
`Inorganic Molecules
`Organic Molecules
`Same Solvents For Liquid Preparations
`Distillation Method
`Ion-exchange method
`Reverse Osmosis
`
`Preparation of Solutions
`Oral Solutions and Preparations for Oral
`Solution
`
`Dry Mixturesfor Solution
`Oral Solutions
`
`Oral Rehydration Solutions
`Oral Colonic Lavage Solution
`Magnesium Citrate Oral Solution
`Sodium Citrate and Citric Acid Oral Solution
`
`Syrups
`Compont of Syrups
`Sucrose and Non—Sumse Basod Sympa
`Antimicrobial Presematioe
`Flavorant
`Colorant
`
`Preparation of Syrups
`Solution with the Aid of Heat
`Solution byAgitation without the Aid of
`Heat
`
`Addition ofSuorose to a Medicated Liquid or
`to a Flavored Liquid
`Percolation
`Elixirs
`
`PIEPaIfithEI‘l of Elixirs
`Nonmedicated Elixirs.
`Medicated Elixirs
`Antihistamine Elixirs
`
`Proper Administration and Use of Liquid
`' Peroral Dosage Forms
`Topical Solutions and Tinctures
`Topical Solutions
`Sprays
`Aluminum Acetate Topical Solution
`Aluminum Subacetate Topical
`Solution
`
`Calcium Hydroxide Topical Solution
`Coal Tar Topical Solution
`Hydrogen Peroxide Topical Solution
`Chlorhexidine Gluconate Solution
`
`Pavilions-iodine Topical Solution
`'l‘liimerosal Topical Solution
`Vaginal and Rectal Solutions
`Vaginal Douches
`Retention Enemas
`Evacuation Enema
`
`Topical Tinctures
`lodlne Tlncture
`
`Compound Benzoin Tinctures
`Thimerosol Tincture
`
`Special Application Solutions
`Nasal Preparations
`Nasal Deoongestant Solutions
`Inhalation Solutions.
`
`Examples ofMedicated inhalation
`Solutions
`inhalants
`
`Amyl Nitrite Inhalant
`Propylliaxedrine Inhalant
`Proper Administration and Use ofNasal
`Drops and Sprays
`Nasal Route for Systemic Efiizcts
`Otic Solutions
`
`Barbiturate Sedation/Hypnotic Elixirs
`Phenobarbital Elixir
`Cemmen-Remooing Solutions
`Digoxin Elixir
`Anti—infective, Anti-inflammatory, and
`Tinctures
`Analgesic Ear Preparations
`
`
`296
`
`AstraZencca Exhibit 2096 p. 5
`
`

`

`Proper Administration and Use ofOtic
`
`Topical Oral (Dental) Solutions
`Miscellaneoas Solutions
`Aromatic Waters
`Diluted Acids
`Spirits
`Nonaqueous Solutions
`Liniment's
`Collodions
`ColIndian
`
`Flexible Collodiorr
`Salicylic Acid- Canadian
`Extraction Methods for Preparing
`Solutions
`Methods of Extraction
`Mammal-ion
`Percolation
`
`Example Preparations Prepared by
`Extraction Processes
`Fluidextracts
`Extracts
`
`IN PHYSICOCHEMCAL terms, solutions may he pre-
`pared from any combination of solid,
`and
`gas, the three states of matter. For example, a solid
`solute may be dissolved in either another solid. 3.
`liquid, oragas, andwiththesame beingtmefora
`liquid solute and for a gas, nine types of homoge-
`neous mixtures are possible. In phamnacy, however,
`mterest in solutions is for the most patt' limited to
`preparations of a solid, a liquid, and less frequently
`a gas solute dissolved in a liquid solvent.
`In pharmaceutical terms, solutions are "liquid
`preparations that contain one or more chemical
`substances dissolved in a suitable solvent or mix-
`
`ture of mutually miscible solvents”(1). Because of a
`particular pharmaceutical solution’s use, it may be
`classified as an oral solution, oiic solution, ophthalmic
`solution, or topical solution. Still other solutions, be—
`cause of their composition or use, may be classified
`as other pharmaceutical dosage forms. For exam—
`ple, aqueous solutions containing a sugar are clas-
`sified as syrups; sweetened hydroalcoholic (combi-
`nations ofwater and ethanol) solutions are termed
`Elixirs,- solutions of aromatic materials are termed
`spirits if the solvent is alcoholic or mficwalefs if
`the solvent is aqueous. Solutions prepared by so
`tracting active constituents from crude drugs are
`termed
`orfluid och-och depending on their
`method of preparation and their concentration.
`Tinctures may also be solutions of chemical sub-
`stances dissolvod in alcohol or in a hydroalcoholic
`solvent. Certain solutions prepared to be sterile and
`pyrogenvfree and intended for parmteral-adnfinis-
`tration are classified as injections. Although other
`examples could be cited, it is apparent that a solu-
`tion, as a distinct type of pharmaceutical prepara-
`tion, is omch further defined than is the physioo-
`chemical definition of the term solution.
`
`Oral solutions, sytups, elirdrs, spirits and tinc-
`nlresare prepared and need for the specific effects
`of the medicinal agents present. In these prepara-
`tions, the medicinal agents are intended to provide
`
`:systernic etieaa'l'he fact that theyare admirlisteted
`in solution fonn usually means that their absorp-
`tion from the gastrointestinal tract into the sys-
`temic circulationmaybe expected to occurmote
`rapidly than from suspension or solid dosage forms
`of the same medicinal agent.
`Salutes other than the medicinal agent are usu-
`ally presentin acaflyadnfinistered solutions.'l‘hese
`additional agents usually are included to provide
`color, flavor, sweetness, or stability to the solution.
`In fountdadng or compoimding a pharmaceutical
`solution, the pharmacist must utilise information
`on the solubility and stability ofeach of the solutes
`present with regard to the solvent or solvent sys-
`tem employed. Combinations of medicinal or
`pharmaceutic agents that will result in chemical or
`physical interactions affording the therapeutic qual-
`ity or pharmaceutic stability of the product must be
`avoided.
`
`For single-solute solutions and especially for
`multiple-solute solutions, the pharmacist must be
`aware of the solubility characteristics of the solutes
`and the {echoes of the common pharmaceutical
`solvents. Each chemical agent has its own solubil-
`ity in a given solvent, For mny medicinal agents,
`their solubilities in the usual solvents are stated in
`the USP aswell as in other reference books.
`
`Solubility
`Attractive forces between atoms lead to the for—
`mation of molecules and ions. The intermolecular
`
`tomes, which are developed between like make
`coins, are responsible for the physical state (i.e.,
`solid, liquid, or gas}. of the substance under giVEn
`conditions, as temperature and pressure; [Rider or-
`dinary conditions. must organic compounds, and
`thus most drugsubotances, form molecular solids.
`When molecules interact,
`forces and re-
`pulsive forces are in edcct.'l'he attractive forces came
`the molecules to cohere, whereas the repulsive
`
`AstraZencca Exhibit 2096 p. 6
`
`

`

`298
`
`Solutions
`
`forces prevent molecular interpenetration and de-
`struction. When the attractive and reptdsive forces
`are equal, the potential energy between two mole—
`colesis minimum and the systemis most stable.
`Dipole: molecules frequently tend to align
`themseIVes with other dipole: molecules such that
`the negative pole of one molecule points toWard
`the positive pole of the other. Large groups of mol-
`ecules may be associated through these weak at-
`tractions known as dipole-dipole or van der Wallis
`forces. In addition to the dipolar interactions. other
`attractions occur between polar and nonpolar mol-
`ecules and ions. These include ion-dipole forces
`and hydrogen bonding. The latter is of par-Hotter
`interest. Because of small size and large electrosta-
`dcfield the hydrogen stomcanmovein closeto an
`electronegative atom, forming an electrostatic type
`of association referred to as a hydrogen bond or hy-
`drogen budge. Hydrogen bonding irWoh-res strongly
`electronegative atoms as oxygen, nitrogen. and flu-
`orine. Such a bond exists in water. represented by
`the dotted lines:
`
`a
`sh.
`.r‘
`I'L
`o
`3&1
`1-1” \H
`Water
`
`Hydrogen bonds also exist between some alcohol
`molecules. esters. carboxylic acids. aldehyd, and
`polypeptides.
`till-ten a solute dissohres. the substances inter-
`molecular forces oE attraction must be overcome by
`forces of attraction batsmen the solute and solvent
`
`molecules'I'his involves breekiogthe solute—solute
`forces and the solvent-solvsnt forces to achieve the
`solute-solvent attraction.
`
`The solubility of an agent in a particular solvent
`indicates the moximron concenlretiorr to which a
`solution may be prepared with that agent and that
`solvent. When a solvent. at a given temperature.
`has dissolved all of the solute it can it is said to be
`saturated. To emphasize the possible variation in
`solubility between twa chemical agents and there-
`fore in the amounts of each required to prepare a
`saturated solution. two oflicial aqueous saturated
`solutions are cited as examples, Calcium Hydroidde
`Topical Solution U312 and Botassium Iodide Oral
`Solution. USP. The first solution, prepared by agi-
`
`tating an excess amount of caldmn hydmodde With
`purified water, contains only about 140 mg of dis-
`solved solute per 100 rnL of solution at 25"C,
`whereas the latter solution contains about 100 g of
`solute per 100 mL of solution, over 700 times as
`much solute as present in the calcium hydroxide
`topical solution. It is-apparent from this compari-
`son that the maximum poasr'ble concentration to
`which a pharmacist may prepare a solution varies
`greatly and is dependent. in part, on the chemical
`constitution of the solute. Through selection of a
`different solubillzing agent or a difierent chemical
`salt form of the medicinal agent, alteration of the
`pH ofa solution or substitution, in part or inwhole,
`of the solvent, a pharmacist can in certain instances
`dieson greater quantifies of a solute than would
`otherwise be possible. For example, iodine gren-
`ules are soluble in water only to the extent of 1 g
`in about 3000 mL of water. Using only these
`two agents, the madmum concentration possible
`would be approximately 0.03% of iodine in aque-
`oussolution. However. through the use ofan aque-
`ous solution of potassium or sodium iodide as the
`solvent, much larger amounts of iodine may be dis—
`solved as the result of the tonnatton of a water-
`
`soluble complex with the iodide salt.This reaction
`is taken advantage of, for example. in Iodine ’lbpi—
`cal Solution, USP. prepared to contain about 2% of
`iodina and 2.4% of sodium iodide.
`
`Thmperamre is an important Eactorin determin-
`ingthe solubility of a- drug and in proper-tog its so—
`Iution Most chemicals absorb heat when they are
`dissoltIed and are said to have a positive heat ofso-
`lotion. resulting in increased solubility with an in-
`crease in temperature. A fen: chemicals have a seg—
`olive heat of solution and exhibit a decrease in
`solubility with a rise in temperature. Other factors,
`in addition to temperature, effect solubility. These
`include the various chemical and other physical
`properties of both the solute and the solvent, fac-
`tors of pressure-,.the acidity or basicityot the solu—
`tion. the state of subditdsiOn of the solute, and the
`physical agitation applied to the solution during
`the dissolving process. The solubility of a pure
`chemical substance at a given temperature and
`pressure is constant; howover, its one of solution,
`that is. the speed at which it dissolves, depends on
`the particle size of the substance and the torrent of
`agitation.'[he liner the powder, the greater the sur-
`face area that comes in contact with the solvent.
`and the more rapid the dissolving process. Also. the
`greater the agitation, the more unsaturated solvent
`passes over the drug and the faster the formation
`of the solution.
`
`AstraZeneca Exhibit 2096 p. 7
`
`

`

`Solutions
`
`299
`
`Table 12.2.. Water and Alcohol Soluhimies of Some
`Selected Weak Acids, Weak Bases. and Their Salli
`
`Numberqu ofSoloent
`Required to Dissolve
`1 g ofDmg
`
`W s
`
`2
`5
`2
`1.280
`325
`.210
`565
`8
`10
`soluble
`‘15
`sparingly soluble
`slightly Still-lb!!!
`
`ome
`Atropine sulfate
`Codeine
`Codeine sulfate
`Codeine phosphate
`Morphine
`Morpholo- sulfate
`Phenobarbital
`thobarbital sodium
`Promote
`Procaine hydrochloride
`Sulfadiazine
`Sodium sulfadiazine
`
`455
`0.5
`120
`30
`2.5
`5.000
`16
`1,000
`1
`200
`'1
`13,000
`2
`
`Although there are-no exactntlesfor
`unerringly the solubility of a cherrucal agent in a
`particular
`liquid,
`atpetienoed pharmaceutical
`chemists can estimate the general solubility of a
`chemical compound based on its molecular struc-
`ture and flmctional groups. The infarct-radon gath—
`ered on a great number of indhrldual charities]
`compounds has led to the characterization of the
`solubilities of groups of compounds, and though
`there may be an occasional inaccurath respect:
`to an individual member of a group of compounds
`the generalizations. nonetheless serve a useful
`function. As demonstrahed by the data in Table 12.2
`and other similar data, salts of organic compounds
`are more soluble in water than are the correspond-
`ing organic bases. Conversely the organic basos are
`more soluble in organic sobents. including alcohol.
`than are the corresponding salt forms. Perhaps the
`most written guideline for the predictiou of solu-
`bility is [haf'like dissolveslikefmeaning that a sol-
`vent having a chemical structure most similar to
`that of the intended solute will be most likely to
`dissolve it'll-nus, organic compounds are more sol-
`uble in organic solvents than in water. Organic
`compounds may, however, be somewhat water-
`soluble if they contain polar groups capable of.
`forming hydrogen bonds With water. In fact. the
`greater the number. of polar groups pressnt, the
`greater will likely be the organic compound’s solu-
`bility in water. Polar groups include 0H,. CHO.
`COH, CHOH, CHpH, COOH. N02. C0,
`and. 50311.1}!!! introduction of halogen atoms into
`
`AstraZencca Exhibit 2096 p. 8
`
`The solubility of a substance in a given solvent
`may be determined by preparing a saturated solu-
`tion of it at a specific tempetahn'e and determining
`by chemical analysis the amount of chemical dis-
`solved in a g‘Ven weight of solution. By simple cal-
`culation, the amount ofsolvent required to dissolve
`the amount of solute can be detemiirtEthe solu-
`
`biliryrnay then be expressed as grams of solute dis-
`solving in milliliters of solvent~—for example,“1 g of
`sodium chloride dissolves in 18 ml. of water.“
`
`When the exact solubility has not been determined,
`general expressions of relative solubility may be
`used. These terms are defined in the USP as- pre-
`sonfiecl in Table 12.1 (2;
`A great many of‘ the important organic medicinal
`agents are either weak acids or weak bases, and
`their-solubility is. dependent to a large measure on
`the pH ofthe submit. These drugs react eitherwith
`strong acids or strong bases to form watervsoluble
`salts. For instance, the weak bases, includinng
`of the alkaloids (atropine, codeine, and morphine).
`antihistamines (diphenyhydrarnine and tripelen—
`nominal, local anesthetics. (cocaine, procaine, and
`belracaine), and other important drugs are not very
`water-soluble, but theyI are soluble in dilute solu-
`tions of acids. Pharmaceutical manufacturers have
`
`prepared many acid salts of these orgardc bases to
`enable the preparation of aqueous solutions. it
`must be recognized, however, that if the pH of the
`aqueous solutions of these salts is changed by the
`of alkali, the free base may separate from
`solution unless it has adequate solubility in water.
`Organic medicinals that are weak acids include the
`barbiturate drugs (as phenobarbital and peatobar-
`bital) and the sulfonarnides (as sulfadiazine and
`sulfacetamide). These and other weak acids form
`water-soluble salts in basic solution and may sepa-
`rate b'om solution by a lowering of the pH. Table
`12.2 presents the comparative solubilities of some
`typical examples otweak acids and weakbasesand
`their salts.
`
`Table 12.1. Relative Teams of Solubility (2}
`
`Descripfim'lbmz
`
`Very soluble
`Freely soluble
`Soluble
`
`Spar-lusty soluble
`Slightly soluble
`Very slightly soluble
`Practically insoluble
`or insoluble
`
`Parts ofSol‘vent Required
`furl PmrofSolute
`
`Less than 1
`From I to 10
`From 10 to 30
`
`From 30 to 100
`From 100 to 1000
`From 1000 to 10.000
`10,000
`over
`
`

`

`300
`
`Solutions
`
`a molecule tends to decrease water-solubility be—
`cause of an increase in the molecular weight of the
`compound without a proportionate increase in po-
`larity. An increase in the molecular weight of an or-
`ganic compound without a change in polarity re-
`sults In decreased solubility in water. Table 12.3
`demonstrates some of these generalities through
`the use ofspecific chemical examples.
`As with organic compounds. the pharmacist is
`aware of some general patterns of solubility that
`apply to inorganic compounds. For instance most
`salts of monovalent cations such as sodium. potas-
`sium, and ammonium are water soluble, whereas
`the divalent cations like calcium magnesium. and
`barium usually form watensoluble compounds
`With rfitrate, acetater and chloride anions but not
`with carbonate, phosphate, or hydroxide anions.'1b
`be sure, there are certain combinations of anion
`and cation that would seem to be similar in make-
`
`up but that do nothave similar solubility character-
`istics. Fori‘nstance, magnesium sulfate (Epsom salt)
`is soluble,I but calcium snifate is only slightly Bolo-
`ble; barium sulfate is very insoluble (1 g dissolves in
`about 400,000 mi. of water) and is used as an
`opaque media for x-ray observation of the intesti-
`nal tart-neti but barium sulfide and barium sulfite- are
`
`not as insoluble, and their oral use can result in poi-
`soning; mercurous chloride {HgCD is insoluble and
`was tonnerly used as a cathartic, but mercuric chlo-
`ride (HgClz) is soluble in water and is a deadly poi-
`son if taken internally.There are many instances in
`which solubilitles of certain drugs and their differ-
`entiation from other drugs are critical to the phar-
`macist in order that he or she might avoid com-
`pounding failures or therapeutic disasters.
`
`Table 12.3. Solubilities of Selected Organic
`Compounds in Water as a Demonstration of
`Chemical Shawna—Solubility
`
`Compound
`
`Formula
`
`Benzene
`Benzoic acid
`Benzyl alcohol
`Phenol
`
`CGHE
`Cal-{4200}!
`Cgl-IECE-IQOH
`Csl-ISOH
`
`oregano
`Carbon tetrachloride
`Chloroform
`Methylene chloride
`
`CsHsloms
`CCI,
`C}ng
`CREE,
`
`Monber :3me
`ofWater
`Required to
`Diesel»: 1 g of
`Compound
`
`1430
`2175
`25
`15
`
`:3
`2.000
`200
`51]
`
`For organic as well as for inorganic solutes, the
`ability of a solvent to dissolve them depends on
`its effectiveness in overcoming the electronic
`forces that hold the atoms of the solute together
`and the corresponding lack of resolute on the
`part of the atoms themselves to resist the solvent
`action. During the dissolution process, the mole-
`cules of the solvent and the solute become
`
`tmiformly mbted and cohesive forces of the atoms
`are replaced by new forces due to the attraction
`of the solute and solvent molecules for one
`another.
`
`The student may find the following general rules
`of solubility usefiil.
`
`Inorganic Molecules
`1. If both the cation and anion of an ionic com-
`
`pound are monmlau, the solute-solute attrac~
`rive forces are usually easily overcome, and
`therefore, these compounds are generallywater
`soluble. (Examples, NaCL LiBt. Kl, NH‘NO,
`NaNOzJ
`2. If only one of the two ions in an ionic com—
`pound is monmient the solute-solute interac-
`tions are also usually easily overcome and the
`compounds are Water soluble.
`(Examples:
`Bach, Mglz, NaZSOy NaaPO‘)
`3. If both the cation and anion are malevolent, the
`solute-solute interaction maybe too great to be
`overcome by the solute-solvent interaction
`and the compound ma.)r have poor mter solu—
`{Exarnplen CaSD‘, BaSOg, BiPOd; Ex-
`ceptions: 21150,, FeSOQ
`4. Common salts of alkali metals (Na, K, Li, Csi
`Rb) are usually Water soluble (Biosphere
`Locos)
`5. Ammonium and quaternary ammonium salts
`are water sohible.
`6. Nitrates, nitrites, acetates, chlorates, and lac-
`
`tates are generally water soluble. (Exceptions:
`silver and mercurous acetate)
`7. Sulfates, sulfites, and tluosulfates are generally
`“rater soluble. (Exceptions: calcium and bar-
`ium salts)
`8. Chlorides-l bromides.I and iodides are water
`soluble. (Emeptions: salts of silver and mer-
`cu'rous ions)
`9. Acid salts corresponding to an insoluble salt
`will be more water soluble than the original
`salt.
`
`10. Hydroiddes and oxides of cumpounds other
`than alkali metal cations and the ammonium
`
`ion are generally water insoluble.
`
`AstraZeneca Exhibit 2096 p. 9
`
`

`

`Solutions
`
`301
`
`1L Sulfides are water insoluble except for their
`aficali metal salts.
`
`12. Phosphates, carbonates, silicates, boretes, and
`hypomlorites are water insoluble except for
`their alkali metal salts and ammonium salts.
`
`Some Solvents For
`
`Liquid Preparations
`
`The following agents find use as solvents in the
`preparation of solutions.
`
`Organic Molecules
`
`1. Molecules having one pole: funcfitmal group
`are usually soluble to total chain lengths of Eye
`carbons-
`
`2. Molecules having branched chains are more
`soluble than the corresponding, straight-chain
`compound.
`3» Water solubility decreases with an increase in
`molecular weight.
`4.. Increased sit-smite! similarity between solute
`and solvent is accompanied by increased solu-
`bility.
`
`It is the pharmacist knowledge of the chemical
`characteristics of drugs that permits the selection of
`the propersolvent fora particular solutel-Iowever,
`in addition to the factors of solubility the selection
`is based on such additional solvent characteristics
`
`as clarity, low toadclty, viscosity, compatibility with
`other Eormulative ingredients, chemical inertness,
`palatability, odor. color, and economy. In most in-
`stances, and especially for solutions to be taken
`orally, used cphmalnucalh’, or injected, water is the
`preferred solvent because it cornea closer to meet-
`ing the majority of the above miseria than the other
`available solvents, In many instancos, when water
`is used as the primary solvent, an auxiliary solvent
`is also employed to augment the solvent action of
`Water or to contribute to a product’s chemical or
`physical stability. Alcohol, glycerin, and propylene
`giycol, perhaps the most used corollary solvents,
`have been quite eflecfiw in contributing to the de-
`sired characteristics of pharmaceutical solutions
`and in maintaining their stability.
`Other solvents, such as acotone, ethyl crude, and
`isopropyl alcohol, are too toadc to be pennitted in
`pharmaceutical preparations to be taken internally,
`but they are useful as reagent solvents in organic
`chemistry and in the preparatory stages of'drug de-
`Velopment, as in the extractions: removal of active
`constituents from medicinal plants. For purposes
`such as this, certainsolvents are officially recognized
`in the compendia. A mtmber of fixed oils, such as
`corn oil, cottonseed oii. peanut oil, and sesame oil,
`some useful solvent Emotions particularly in the
`preparation of oleaginous injections and are recog-
`nized in the oflicial compendia for this purpose.
`
`Alcohol, use (EthylAlcohol,
`Ethanol, cszom
`Next to water, alcohol is the most useful solvent
`in pharmacy. It is used as a primary solvent for
`many organic componmds. Together with water it
`forms a hydroalcoholic mixture that dissolves'both
`alcohol—soluble and water-soluble substances a
`feature especially usufixl in the extraction ofactive
`constituents from crude drugs. By varying the pro-
`portion of the two agents, the active constituents
`may be selectively dissolved and extracted or al—
`lowed to remain behind accordingto their particu-
`lar' solubility characteristics in the menstruum. Al-
`cohol, USP, is 94.9 to 96.0% QH50H by volume
`(i.e., WV) when determined at 15.56‘C, the US.
`Government's standard temperature for alcohol
`determinations. Dehydrated Alcohol, USP, contains
`not loss than 99.5% Czl-isCJI-I by volume and is uti-
`lized in instances in which an essentiallywater—foee
`alcohol is desired.
`
`Alcohol has been Well recogniZed as a solvent
`and enipient in the formulation of oral pharma-
`ceutical products. Certain dnrga are insoluble in
`water and must be dissolved in an alternate vehi-
`
`deAlcohol is often preferred because of its misci-
`bilitywith watermle abilityto dissolvemany
`water-insoluble ingredients, including drug sub-
`stances, flavorants, and
`presenzetives.
`Alcohol is frequently used with other solvents, as
`glycols and glycerin. to reduce-the amount of alco—
`hol required. It also is used in
`products as an.
`antimicrobial preservative alone or as a copreserv-
`ative with parabens, benzoates, sorbates, and other
`agents.
`Howaver, aside from its pharmaceutic advan-
`tages as a solvent and preset-same, concern has
`been expressed over the undesired pharmemlogic
`and potential toad: efl’ects of alcohol when ingested
`in pharmaceutical products particularly by child-
`ren'l‘hus, theFDAhas proposed that: manufactur-
`ers of OTC oral drug products resn-ict. insofar
`as possible, the use of alcohol and include appro-
`priate warnings in the labeling. For OTC oral prod-
`ucts intended for d'tildren. under 6 years of age, the
`recommended alcoh01~content limit is 0.5%; for
`
`products intended for children 6 to 12 years of age,
`the recommended limit is 5%; and for products
`
`Astra-Zoneca Exhibit 2096 p. 10
`
`

`

`302
`
`Solutions
`
`recommended forchildren over 12 years of age and
`for adults, the recommended limit is 10%.
`
`Diluted Alcohol, NP
`
`Diluted Alcohol, NE is prepared by mixing equal
`volumes of Alcohol, USP, and Purified Waten USP!
`The finalvolumeofsuch mbeturesisnotthesumof
`
`the individual volumes of the two components, but
`due to contraction of the liquids upon mixing, the fi-
`nal volume is generally about 3% less than what
`would normally be expected. Thus when 50 mL of
`each component is combined, the resulting product
`measures approximately '97 mL. It is for this reason
`that the attengtb of Diluted Alcohol, NE is not ex-
`actly half that of the more concentrated alcohol, but
`slightly greater, approfimately 49 it. Diluted alcohol
`is a useful hydroalooholic solvent in various phar-
`maceutical processés and preparations.
`
`Alcohol, Rubbing
`
`RubbingAlcohol contains about 70% of ethyl al-
`cohol by volume, the remainder consisting of wa-
`ter, denaturants With or without COIor additives and
`perfume oils, and stabilizers. In each 100 mi, it
`must contain not less than 355 mg of sucrose oc-
`taecetate or 1.4 mg of denatonium benzoate, bitter
`substances that discourage accidental or abusive
`oral ingestion. The denaturants employed in rub-
`bing alcohol areaocording to the Internal Revenue
`Service, US. 'lteasure Department, Fonnula 23-H,
`which is composed oft! parts byvolumeof acetone,
`15 parts byvolurne of methyl isobutyl ketone, and
`100 parts byvolume of ethyl alcohol.'I'he use of this
`denaturant mixmre makes the separation of ethyl
`alcohol from the denaturants a
`impossible
`task with ordinary distillation apparatus. This dis-
`courages the illegal removal and use as a beverage
`of the alcoholic content of rubbing. alcohol.
`The product is volatile and flammable and should
`be stored in tight containers remote from fire. It is
`employed as a rubefacient maternally andasa sooth-
`ing rub for bedridden patients, a genrficide for in-
`struments, and a skin cleanser prior to injection. It is
`also used as a vehicle for topical preparations.
`Symonym: Alcohol Rubbing Compound.
`
`Glycerin, LISP (Glycerol),
`mon'CHOH-CHzofl
`
`Glycerin is a clear syrupy liquid with a sweet
`taste. It is miscible both with water and alcohol. As
`a solvent. it is comparable with alcohol, but because
`
`ofits viscosity; solutes are slowly soluble in it unless:
`it is rendered less viscous by heating. Glycerin has.
`presarvative qualities and is often used as a staid-,-
`lizer and as an auxiliary solvent in conjunction with
`water or alcohoL It is used in many internal prepa-
`rations.
`
`Isopropyl Rubbing Alcohol
`
`Isopropyl Rubbing Alcohol is about 70% byvol-
`ume isopropyl alcohol. the remainder consisting of
`water with or without color additives, stabilizers,
`and perfume oils. It is used externally as. a robot:-
`cient and soothing rub and as a vehicle for topical
`products. This preparation and. a commercially
`available 91% is'optopyl alcohol solution are com—
`monly employed by diabetic patients in preparing
`needles and syringes for hypodermic injections of
`insulin and for disinfecting the-skin
`
`Propylene Glycol, USP,
`ChautZ'HiOIDCHZOH
`
`Propylene glycol, a viscous liquid, is miscible
`with water and alcohol. It is a useful solvent with a
`
`wide range of applications and is frequently substi-
`tuted for glycerin in modern pharmaceutical for-
`mulations.
`
`Purified Water, use H20
`
`Naturally occurring water exerts-its solvent effect
`on most substances it contacts and thus is import
`and contains varying amounts of dissole inor-
`ganic salts, usually sodium. potassium, calcium.
`magnesium, and iron, chlorides, sulfates, and bi—
`carbonates, as well as dissolved and undissohred
`organic matter and microorganisms. Water found
`in most cities and towns where water is purified for
`drinking purposes usually contains less than 0.1%
`of total solids, determined by evaporating a 100 ml.
`sample of water to dryness and weighing the
`residue (which would weigh less than 100 mg).-
`Drlnlring Water must meet the United StateS Pub—
`lic Health Service regulations with respect to bar:-
`teriological purity. Acceptable drmking water
`should be clear, colorless, odorless, and neutral or
`only slightly acid or alkaline, the deviation ham
`neutral being due to the nature of the dissolved
`solids and gases (carbon diordde contributingto the
`acidity and ammonia to the alkalinity of water).
`Ordinary drinking

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket